Cargando…
Development of Sensitive Droplet Digital PCR Assays for Detecting Urinary TERT Promoter Mutations as Non-Invasive Biomarkers for Detection of Urothelial Cancer
SIMPLE SUMMARY: The gold standard method for the diagnosis of bladder cancer (BC) is the invasive and expensive cystoscopy. Telomerase reverse transcriptase (TERT) promoter mutations occur frequently (60–90%) in BC. In this study, we developed highly sensitive droplet digital PCR (ddPCR) assays for...
Autores principales: | Hosen, Md Ismail, Forey, Nathalie, Durand, Geoffroy, Voegele, Catherine, Bilici, Selin, Avogbe, Patrice Hodonou, Delhomme, Tiffany Myriam, Foll, Matthieu, Manel, Arnaud, Vian, Emmanuel, Meziani, Sonia, De Tilly, Berengere, Polo, Gilles, Lole, Olesia, Francois, Pauline, Boureille, Antoine, Pisarev, Eduard, Salas, Andrei R. O. S. E., Monteiro-Reis, Sara, Henrique, Rui, Byrnes, Graham, Jeronimo, Carmen, Scelo, Ghislaine, McKay, James D., Calvez-Kelm, Florence Le, Zvereva, Maria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7761513/ https://www.ncbi.nlm.nih.gov/pubmed/33260905 http://dx.doi.org/10.3390/cancers12123541 |
Ejemplares similares
-
Urinary TERT promoter mutations as non-invasive biomarkers for the comprehensive detection of urothelial cancer
por: Avogbe, Patrice Hodonou, et al.
Publicado: (2019) -
Urinary TERT promoter mutations are detectable up to 10 years prior to clinical diagnosis of bladder cancer: Evidence from the Golestan Cohort Study
por: Hosen, Md Ismail, et al.
Publicado: (2020) -
Circulating tumour-derived KRAS mutations in pancreatic cancer cases are predominantly carried by very short fragments of cell-free DNA
por: Zvereva, Maria, et al.
Publicado: (2020) -
Activating Telomerase TERT Promoter Mutations and Their Application for the Detection of Bladder Cancer
por: Zvereva, Maria, et al.
Publicado: (2020) -
Elucidating Genomic Characteristics of Lung Cancer Progression from In Situ to Invasive Adenocarcinoma
por: Vinayanuwattikun, Chanida, et al.
Publicado: (2016)